본문 바로가기
KERD
논문KCI 등재

Fermented Soymilk Alleviates Lipid Accumulation by Inhibition of SREBP-1 and Activation of NRF-2 in the Hepatocellular Steatosis Model

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류생물학

초록

Ingredients of soy and fermented soy products have been widely utilized as food supplements for health-enhancing properties. The aim of this study was to evaluate the effects of fermented soymilk (FSM) and soymilk (SM) on free fatty acid-induced lipogenesis in the hepatocellular steatosis model. HepG2 cells were incubated with palmitic acid (PA) for 24 h to induce lipogenesis and accumulation of intracellular lipid contents. The PA-treated cells were co-incubated with FSM, SM, genistein, and estrogen, respectively. Lipid accumulation in the PA-treated HpG2 cells was significantly decreased by co-incubation with FSM. Treatment of HepG2 cells with PA combined with genistein or estrogen significantly increased the expression of SREBP-1. However, FSM co-incubation significantly attenuated SREBP-1 expression in the PA-treated HepG2 cells; in addition, expression of NRF-2 and phosphorylation of ERK were significantly increased in the PA and FSM co-incubated cells. PA-induced ROS production was significantly reduced by FSM and SM. Our results suggested that the bioactive components of FSM could protect hepatocytes against the lipid accumulation and ROS production induced by free fatty acids. These effects may be mediated by the inhibition of SREBP-1 and the activation of NRF-2 via the ERK pathway in HepG2 cells.

Abstract

Ingredients of soy and fermented soy products have been widely utilized as food supplements for health-enhancing properties. The aim of this study was to evaluate the effects of fermented soymilk (FSM) and soymilk (SM) on free fatty acid-induced lipogenesis in the hepatocellular steatosis model. HepG2 cells were incubated with palmitic acid (PA) for 24 h to induce lipogenesis and accumulation of intracellular lipid contents. The PA-treated cells were co-incubated with FSM, SM, genistein, and estrogen, respectively. Lipid accumulation in the PA-treated HpG2 cells was significantly decreased by co-incubation with FSM. Treatment of HepG2 cells with PA combined with genistein or estrogen significantly increased the expression of SREBP-1. However, FSM co-incubation significantly attenuated SREBP-1 expression in the PA-treated HepG2 cells; in addition, expression of NRF-2 and phosphorylation of ERK were significantly increased in the PA and FSM co-incubated cells. PA-induced ROS production was significantly reduced by FSM and SM. Our results suggested that the bioactive components of FSM could protect hepatocytes against the lipid accumulation and ROS production induced by free fatty acids. These effects may be mediated by the inhibition of SREBP-1 and the activation of NRF-2 via the ERK pathway in HepG2 cells.

참고문헌 (49)

  1. Shaker M, "Liver transplantation for nonalcoholic fatty liver disease: new challenges and new opportunities", World J. Gastroenterol., 20, pp.5320~5330 (2014)[DOI]
  2. Rinella ME, "Nonalcoholic fatty liver disease: a systematic review", JAMA, 313, pp.2263~2273 (2015)[DOI]
  3. Browning JD, "Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity", Hepatology, 40, pp.1387~1395 (2004)[DOI]
  4. Lavine JE, "Nonalcoholic fatty liver disease in the pediatric population", Clin. Liver Dis., 8, pp.549~558 (2004)
  5. Reddy JK, "Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation", Am. J. Physiol. Gastrointest. Liver Physiol., 290, pp.G852~G858 (2006)
  6. Farrell GC, "Nonalcoholic fatty liver disease: from steatosis to cirrhosis", Hepatology, 43, pp.S99~S112 (2006)[DOI]
  7. Durazzo M, "Focus on therapeutic strategies of nonalcoholic fatty liver disease", Int. J. Hepatol., 2012, pp.464706~ (2012)
  8. Leamy AK, "Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease", Prog. Lipid Res., 52, pp.165~174 (2013)[DOI]
  9. Malhi H, "Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity", Gut, 56, pp.1124~1131 (2007)[DOI]
  10. Feldstein AE, "Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis", Gastroenterology, 125, pp.437~443 (2003)[DOI]
  11. Kim NH, "Lipid profile lowering effect of Soypro fermented with lactic acid bacteria isolated from kimchi in high-fat dietinduced obese rats", Biofactors, 33, pp.49~60 (2008)[DOI]
  12. Kaizu H, "Effect of antioxidative lactic acid bacteria on rats fed a diet deficient in vitamin E", J. Dairy Sci., 76, pp.2493~2499 (1993)
  13. Perdigon G, "Prevention of gastrointestinal infection using immunobiological methods with milk fermented with Lactobacillus casei and Lactobacillus acidophilus", J. Dairy Res., 57, pp.255~264 (1990)[DOI]
  14. Shahani KM, "Role of dietary lactobacilli in gastrointestinal microecology", Am. J. Clin. Nutr., 33, pp.2448~2457 (1980)[DOI]
  15. Choi YM, "Hypolipidemic effect of lactobacillus ferment as a functional food supplement", Phytother. Res., 20, pp.1056~1060 (2006)[DOI]
  16. Shida K, "Lactobacillus casei inhibits antigeninduced IgE secretion through regulation of cytokine production in murine splenocyte cultures", Int. Arch. Allergy Immunol., 115, pp.278~287 (1998)[DOI]
  17. Park DJ, "Characteristics of yogurt-like products prepared from the combination of skim milk and soymilk containing saccharifiedrice solution", Int. J. Food Sci. Nutr., 56, pp.23~34 (2005)[DOI]
  18. Kang MS, "Physico-chemical characteristics and <TEX>${\beta}$<", TEX>-galactosidase activity of Lactobacillus plantarum from kimchi, 1996, pp.39, 54~59
  19. Lin FM, "Fermentation of a milksoymilk and Lycium chinense Miller mixture using a new isolate of Lactobacillus paracasei subsp. paracasei NTU101 and Bifidobacterium longum", J. Ind. Microbiol. Biotechnol., 31, pp.559~564 (2004)
  20. Liu JR, "Hypocholesterolaemic effects of milk-kefir and soyamilkkefir in cholesterol-fed hamsters", Br. J. Nutr., 95, pp.939~946 (2006)[DOI]
  21. Kun Chen, "Regulation of the Lactobacillus Strains on HMGCoA Reductase Gene Transcription in Human HepG2 Cells via Nuclear Factor-κB", Journal of Microbiology and Biotechnology, 26(2), pp.402~407 (2016), 한국미생물·생명공학회[DOI]
  22. Kersten S, "Mechanisms of nutritional and hormonal regulation of lipogenesis", EMBO Rep., 2, pp.282~286 (2001)[DOI]
  23. 김애향, "A Mixture of Ethanol Extracts of Persimmon Leaf and Citrus junos Sieb Improves Blood Coagulation Parameters and Ameliorates Lipid Metabolism Disturbances Caused by Diet-Induced Obesity in C57BL", 6J Mice, 2016, pp.26(2), 295~308[DOI]
  24. 강수경, "Phytoncide Extracted from Pinecone Decreases LPS-Induced Inflammatory Responses in Bovine Mammary Epithelial Cells", Journal of Microbiology and Biotechnology, 26(3), pp.579~587 (2016), 한국미생물·생명공학회[DOI]
  25. Donohue TM Jr., "Alcohol-induced steatosis in liver cells", World J. Gastroenterol., 13, pp.4974~4978 (2007)[DOI]
  26. Kim JH, "Resveratrol inhibits genistein-induced multi-drug resistance protein 2 (MRP2) expression in HepG2 cells", Arch. Biochem. Biophys., 512, pp.160~166 (2011)[DOI]
  27. Kelly LA, "Estrogen receptor alpha augments changes in hemostatic gene expression in HepG2 cells treated with estradiol and phytoestrogens", Phytomedicine, 21, pp.155~158 (2014)[DOI]
  28. Smutny T, "U0126, a mitogen-activated protein kinase kinase 1 and 2 (MEK1 and 2) inhibitor, selectively up-regulates main isoforms of CYP3A subfamily via a pregnane X receptor (PXR) in HepG2 cells", Arch. Toxicol., 88, pp.2243~2259 (2014)
  29. Tezuka H, "Immunomodulatory effects of soybeans and processed soy food compounds", Recent Pat. Food Nutr. Agric., 7, pp.92~99 (2015)[DOI]
  30. Imai S, "Functional properties of soybean and processed soy foods ingredients", Recent Pat. Food Nutr. Agric., 7, pp.74~ (2015)[DOI]
  31. Zhang EJ, "Extraction and purification of isoflavones from soybeans and characterization of their estrogenic activities", J. Agric. Food Chem., 55, pp.6940~6950 (2007)
  32. Sakai T, "Soy isoflavones and immunity", J. Med. Invest., 55, pp.167~173 (2008)[DOI]
  33. Mohamed SS, "Genistein improves liver function and attenuates non-alcoholic fatty liver disease in a rat model of insulin resistance", J. Diabetes, 1, pp.278~287 (2009)[DOI]
  34. Ferre P, "Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c", Diabetes Obes. Metab., 12(Suppl 2), pp.83~92 (2010)[DOI]
  35. Eberle D, "SREBP transcription factors: master regulators of lipid homeostasis", Biochimie, 86, pp.839~848 (2004)[DOI]
  36. Gold R, "Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis", N. Engl. J. Med., 367, pp.1098~1107 (2012)[DOI]
  37. Houghton CA, "Sulforaphane and other nutrigenomic Nrf2 activators: can the clinician's expectation be matched by the reality?", Oxid. Med. Cell. Longev., 2016, pp.7857186~ (2016)
  38. Balkwill F, "Iflammation and cancer: back to Virchow?", Lancet, 357, pp.539~545 (2001)
  39. Yang Y, "Chemoprevention of dietary digitoflavone on colitis-associated colon tumorigenesis through inducing Nrf2 signaling pathway and inhibition of inflammation", Mol. Cancer, 13, pp.48~ (2014)[DOI]
  40. Klaunig JE, "Oxidative stress and oxidative damage in chemical carcinogenesis", Toxicol. Appl. Pharmacol., 254, pp.86~99 (2011)
  41. Lee JS, "Nrf2 as a novel molecular target for chemoprevention", Cancer Lett., 224, pp.171~184 (2005)[DOI]
  42. Sharma S, "Screening of potential chemopreventive agents using biochemical markers of carcinogenesis", Cancer Res., 54, pp.5848~5855 (1994)
  43. Cerutti PA, "Prooxidant states and tumor promotion", Science, 227, pp.375~381 (1985)[DOI]
  44. Froyen EB, "Soy isoflavones increase quinone reductase in hepa-1c1c7 cells via estrogen receptor beta and nuclear factor erythroid 2-related factor 2 binding to the antioxidant response element", J. Nutr. Biochem., 22, pp.843~848 (2011)[DOI]
  45. Setchell KD, "S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora", Am. J. Clin. Nutr., 81, pp.1072~1079 (2005)[DOI]
  46. Zhang T, "Estrogen receptor and PI3K", Akt signaling pathway involvement in S-(-)equol-induced activation of Nrf2, PLoS One, pp.2013, 8[DOI]
  47. Roskoski R Jr., "ERK1", 2 MAP kinases: structure, function, and regulation, 2012, pp.66, 105~143
  48. Knebel B, "Phosphorylation of sterol regulatory elementbinding protein (SREBP)-1c by p38 kinases, ERK and JNK influences lipid metabolism and the secretome of human liver cell line HepG2", Arch. Physiol. Biochem., 120, pp.216~227 (2014)[DOI]
  49. Kotzka J, "Sterol regulatory element binding proteins (SREBP)-1a and SREBP-2 are linked to the MAPkinase cascade", J. Lipid Res., 41, pp.99~108 (2000)

관련 논문AI추천

Standardized rice bran extract improves hepatic steatosis in HepG2 cells and ovariectomized ratsCho Suengmok, Jeon Hyejin, Jung Jonghoon, Kim Minji, Kwon Sangoh, Lim Dong Wook, Um Min Young, Yoon Minseok한국영양학회 · Nutrition Research and Practice2020 · 제14권 제6호비알코올성 지방간 세포 모델에서 곤포의 효능과 기전 연구이인, 권민정, 권정남, 김소연, 박성하, 주명수, 최준용, 한창우, 홍진우대한한방내과학회 · 대한한방내과학회지2014 · 제35권 제2호중만분소환 추출물이 Palmitate로 유발된 비알코올성 지방간 HepG2 cell 모델에 미치는 영향이지원, 전상윤, 최창원, 하예진, 한창우대한한방내과학회 · 대한한방내과학회지2016 · 제37권 제3호고당 및 올레산으로 유도된 HepG2 세포에서 국내산 호두(Juglans regia) 추출물의 비알코올성 지방간 질환 개선 효과이욱, 강진용, 고민지, 김민지, 김종민, 김태윤, 문종현, 이효림, 정혜린, 주승겸, 허호진한국식품저장유통학회 · Food Science and Preservation2022 · 제29권 제5호적소두가 비알코올성 지방간 질환 세포 모델에 미치는 효과이인, 권민정, 권정남, 김소연, 박성하, 서지윤, 장영숙, 주명수, 최준용, 한창우, 홍진우한의병리학회 · 동의생리병리학회지2013 · 제27권 제6호Free fatty acid-induced histone acetyltransferase activity accelerates lipid accumulation in HepG2 cells박재호, 최효경, Jin-Taek Hwang, Sangwon Chung한국영양학회 · Nutrition Research and Practice2019 · 제13권 제3호

이 간행물의 다른 논문 (9건)